Benzinga | Jun 16, 2021 03:59PM EDT

Blueprint Medicines Wins FDA Approval For AYVAKIT Efficacy For Adults With Advanced Systemic Mastocytosis

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212608